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Abstract 
Oral fluid is currently used by Australian and international law enforcement agencies and 
employers to detect recent use of cannabis and other drugs of abuse. The main psychoactive 
constituent of cannabis, ∆9-tetrahydrocannabinol (THC), is highly lipophilic and losses occur 
when in contact with plastic, possibly due to its adsorption onto the plastic surface. This 
study aims to investigate factors governing the interaction of THC with plastic and search for 
ways of overcoming such interaction so to improve THC recovery. As polypropylene is one 
of the most common types of plastic used in collection devices, it was the focus of this study. 
All experiments were done by preparing neat oral fluid samples spiked with THC in 2-mL 
polypropylene centrifuge tubes. Samples were transferred with or without prior addition of 
Triton® X-100 (0.25%) to glass tubes containing d3-THC as internal standard and 0.1 M 
phosphate buffer was then added. Samples were extracted by liquid-liquid extraction using 
hexane/ethyl acetate (9:1 v/v), dried and analysed by gas chromatography-mass spectrometry 
(GC–MS) after derivatisation. No significant difference was found in terms of THC loss to 
plastic when the concentration ranged from 25–1000 ng/mL in the same volume of oral fluid. 
Varying the oral fluid volume (0.5–1.5 mL) while keeping THC at a constant concentration 
showed an upward trend with more loss associated with lower volumes. The use of Triton® 
X-100 significantly decreased the adherence of THC to the plastic tubes and increased the 
THC transfer (>96%) at all volumes tested. Degradation of THC during storage was also 
studied over a 4-week period and it was found that azide did not seem to play a significant 
role in preserving THC in oral fluid. 
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1. Introduction 
THC is one of the major drugs of concern in police roadside testing programs as well as in 
workplace drug testing due to its high prevalence around the world. Oral fluid is an 
increasingly popular matrix to use in drug testing for a number of reasons, including its non-
invasive collection, reduced risk of adulteration, a shorter window of detection and thus a 
more useful indicator of very recent ingestion than urine [1-5].  
Many commercial oral fluid collection devices are available, several of them containing some 
form of stabilising buffer which dilutes the oral fluid collected. Previous studies have found 
that these devices often have difficulty collecting consistent volumes of oral fluid and 
accurate quantification of THC can be challenging [2, 3]. Expectoration is also problematic 
due to issues such as ‘dry mouth’ and foaming but it is still a viable collection technique, 
especially since it is the only way to analyse an accurate volume of oral fluid. Hence, it is 
important to know what interactions THC may have with the containers in which the samples 
are stored. 
Sample containers are commonly made from polypropylene and such containers have been 
used in recent studies involving oral fluid [6-9]. Polypropylene was chosen for this study to 
investigate the adsorptive properties of THC to plastic surfaces when in the oral fluid matrix 
and also to observe any losses that occur during storage for up to 4 weeks. 
 
2. Materials and methods 
2.1. Materials 
Capped polypropylene centrifuge tubes of 2-mL volume were obtained from Scientific 
Specialties Inc. (Lodi, CA, USA). THC-free oral fluid was provided from volunteers and 
used for the study on the day of collection. The absence of THC in collected oral fluid was 
Page 4 of 17 
 
confirmed by following the sample preparation and analysis procedures described in the 
following paragraphs.  
All solvents and chemicals used were analytical grade or higher. Methanol (MeOH) and ethyl 
acetate was obtained from RCI Labscan Limited (Bangkok, Thailand). N-Hexane was 
obtained from Scharlab (Barcelona, Spain). All water used was purified using an Arium 
Milli-Q system from Sartorius AG (Göttingen, Germany). THC (1 mg/mL in MeOH) and d3-
THC (0.1 mg/mL in MeOH) were purchased from Cerilliant (Austin, TX, USA). These 
reference standards were diluted with methanol to obtain working stock solutions for THC at 
50 µg/mL and d3-THC at 25 µg/mL. Di-sodium hydrogen orthophosphate anhydrous 
(Na2HPO4) and sodium dihydrogen orthophosphate monohydrate (NaH2PO4), used to make 
0.1 M Sørensen’s phosphate buffer were sourced from Ajax Chemicals (Auburn, Australia) 
and mixed to achieve pH of approximately 6. N,O-bis(trimethylsilyl)trifluoroacetamide 
(BSTFA) with 1% trimethylchlorosilane (TMCS) was sourced from United Chemical 
Technologies (Bristol, PA, USA). Triton® X-100 was obtained from Sigma–Aldrich (Louis, 
MO, USA), sodium azide was obtained from BDH Laboratory Supplies (Poole, England), 
and Cozart® DDS buffer was obtained from Alere (Brisbane, Australia).  
2.2. Sample preparation and liquid-liquid extraction (LLE) 
Aliquots of freshly collected drug-free oral fluid were transferred into 2-mL polypropylene 
centrifuge tubes and spiked with THC standards in methanol at various specified 
concentrations. The absolute concentration of methanol in these spiked oral fluid samples 
was less than 4%. After capping, the sample tubes were vortex-mixed to ensure complete 
contact between sample and plastic surface. Unless otherwise specified, samples thus 
prepared were decanted into 10-mL screw-cap glass test tubes to avoid further contact with 
additional plastic surfaces. The centrifuge tubes were weighed before and after sampling to 
account for liquid loss from the decanting process. Deuterated internal standard solution (5 
µg/mL) was added to the glass test tubes followed by addition of Sørensen’s phosphate buffer 
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(1 mL). Hexane/ethyl acetate (2.5 mL; 9:1 v/v) was then added and the tubes placed on a 
roller mixer on moderate speed for 60 min. The organic upper layers (2 mL) were transferred 
into high recovery GC–MS vials (1.5 mL; PM Separations, Brisbane, Australia) and 
evaporated under a gentle stream of N2 gas at 40 °C. Residues were reconstituted in 75 µL 
ethyl acetate and 50 µL BSTFA with 1% TMCS and heated at 75 °C for 20 min before 
analysis by GC–MS. 
2.3. GC–MS 
Chromatographic analyses were carried out using an Agilent 7890A/5975C GC–MS system 
with an Agilent 19091S capillary column (30 m × 250 µm × 0.25 µm). Splitless mode was 
used for injection and 2 µL were injected. The injector temperature was 280 °C. The oven 
was operated at an initial temperature of 140 °C for one minute, then increased at 40 °C/min 
to 300 °C and held for 2 min. MS was operated in SIM mode monitoring the TMS derivatives 
of THC and d3-THC at m/z 386, 371 and 303 for THC and m/z 389, 374 and 306 for d3-THC. 
The underlined ions were used for quantification. All calibration standards and samples were 
run in triplicate. 
Data acquisition and analysis were performed using the included Agilent MSD ChemStation 
software package.  
2.4. Validation studies 
Serial dilution of the working stock solution of THC gave eight concentrations of THC in 
MeOH: 50, 25, 10, 5, 2.5, 1, 0.5, 0.25 µg/mL. 10 µL of each of these eight were spiked into a 
separate tube containing 500 µL drug-free oral fluid resulting in concentrations of 1000, 500, 
250, 100, 50, 25, 10, and 5 ng/mL. Internal standard was then added to each tube (10 µL) 
giving a concentration of 500 ng/mL of d3-THC. After addition of 1 mL of 0.1 M Sørensen’s 
phosphate buffer (pH ~5.7), the LLE procedure was followed as previously described. 
Linearity of the calibration curve was calculated using a line of best fit with the acceptable 
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correlation factor set at >0.99. Inter- and intra-day precision and accuracy studies were 
carried out using quality control (QC) samples spiked at 15, and 75 ng/mL (n = 5). Accuracy 
was determined to be acceptable if the calculated concentrations fell within 15% of the 
concentration spiked (expressed as a percentage mean relative error or MRE). Precision was 
deemed acceptable if the percentage relative standard deviation (RSD) was <15%. The limit 
of detection (LOD) was the lowest concentration of analyte that was observed as a peak in the 
chromatograms at all monitored ion fragments. The limit of quantification (LOQ) was the 




3.1. Method validation 
Linearity of the GC–MS method was achieved over the range of 5–1000 ng/mL with a 
correlation coefficient of 0.9990. The intra- and inter-day precision and accuracy of the 
method were satisfactory and are summarised in Table 1. The RSD values were 2.52–8.57% 
and the MRE ranged from 1.38% to 6.48%. 
The LOD was determined to be 1 ng/mL. The LOQ was found to be 5 ng/mL. Precision and 
accuracy at this concentration level was determined to be 3.14% and 9.73% respectively.  
3.2. Plastic surface and THC recovery 
When THC was spiked into 1.5 mL neat oral fluid at six different concentrations (25, 50, 100, 
250, 500 and 1000 ng/mL), all samples experienced a similar degree of THC loss to the 
polypropylene tubes, ranging from 22.8% to 29.3% (Figure 1). The concentration of THC in 
oral fluid samples of equal volume did not appear to affect the degree of adsorption to the 
plastic surface.  
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In contrast, when different volumes (0.5, 1.0 and 1.5 mL) of oral fluid containing the same 
concentration of THC (100 ng/mL) were tested, there was an apparent trend of increasing 
loss in lower oral fluid volumes (Figure 2). 
3.3. Surfactant and THC recovery 
THC loss to the plastic was found to be significantly minimised during repeated experiments 
in which Triton® X-100 (0.25%, approximately 10 times the critical micelle concentration or 
CMC) was mixed with the THC-spiked oral fluid samples before transfer to the glass test 
tubes for liquid-liquid extraction. As shown in Figure 2, the use of Triton® X-100 resulted 
in >96% recovery of THC from the polypropylene containers at all oral fluid volumes tested. 
It was also noted that the absolute signal intensities of d3-THC following extraction from the 
glass test tubes increased significantly when Triton® X-100 was present compared to the 
control experiments in which Triton® X-100 was not utilised (Figure 3). 
3.4. Oral fluid proteins and THC recovery 
In order to investigate the role of oral fluid proteins in THC recovery from the plastic surface, 
THC-fortified oral fluid samples were centrifuged at 7000 rpm for 10 min and the resulting 
protein pellets were collected, reconstituted in phosphate buffer and assayed for THC content. 
It was found that 51.7% of THC was recovered from the protein pellet fraction, while 28.8% 
of THC was recovered from the supernatant, giving a total THC recovery of 80.5%. In a 
parallel experiment in which Triton® X-100 was added into the polypropylene tube that 
contained the protein pellet, an additional 14.7% of THC was recovered, raising the total 
THC recovery to 95.2% (Figure 4).  
To further investigate the role of proteins in THC recovery from plastic surfaces, THC was 
spiked into Sørensen’s phosphate buffer and its recovery was compared with that fortified in 
oral fluid. When THC (100 ng/mL) was spiked in phosphate buffer (0.5 and 1.5 mL), a very 
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low recovery was observed: 24.5% in 0.5 mL buffer and 48.1% in 1.5 mL buffer (Figure 5). 
The extraction efficiency of the liquid-liquid extraction method was also determined for THC 
spiked into phosphate buffer with and without the addition of Triton® X-100. These 
extractions were carried out directly in the glass test tubes and did not involve any transfer 
from plastic tubes. The results showed a high recovery of THC even without the additive. 
From the plain phosphate buffer extractions approximately 90% of THC was recovered; 
when Triton® X-100 was present, the recovery increased to 106% when compared to control 
samples which had not undergone extraction.   
3.5. Storage conditions and THC recovery  
The effect of sodium azide on THC recovery following various storage protocols was 
investigated. Oral fluid (250 µL) fortified with THC (50 ng/mL) in polypropylene centrifuge 
tubes was mixed with 750 µL of either Sørensen’s phosphate buffer alone, Sørensen’s 
phosphate buffer with azide (1%), or the Cozart® DDS buffer containing 0.1% azide. These 
samples were stored either at 4 °C in a refrigerator or at 20 °C in a cabinet for up to 4 weeks. 
After addition of Triton® X-100, aliquots (500 µL) of these samples were analysed for THC 
content. 
As shown in Figure 6, samples treated with the Cozart® buffer suffered only a minimal loss 
of THC over the 4-week period while refrigerated, but even at room temperature the losses 
were small. More loss was observed in samples treated with phosphate buffer and azide, 
however these losses were still minimal up to 3 weeks into storage in a refrigerator. The 
samples kept at room temperature however, showed a larger loss and both treatments resulted 
in 40–50% loss of THC by the end of the 4 weeks. Whilst the phosphate buffer treated 
samples lost more THC by the fourth week, up until then there was minimal difference 
between the concentrations of THC found in these samples and the samples treated with azide. 
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4. Discussion 
THC is known to be highly lipophilic and poorly water soluble, having a high octanol/water 
partition coefficient (log P = 6.97) [10]. It is therefore generally accepted that THC can 
interact with the non-polar plastic material via non-covalent interactions and adsorb to plastic 
container surfaces. It is also possible that THC degrades readily in oral fluid by way of 
metabolic action of microorganisms present in the matrix. Both these forces can be overcome 
by use of buffers containing surfactants and preservatives, a practice followed by some 
commercial manufacturers supplying oral fluid collecting devices. However for the purpose 
of drug testing, these buffers significantly dilute the oral fluid and no collection device can 
accurately measure the absolute volume of oral fluid collected, making concentrations 
detected difficult to interpret. 
In our study we have shown that storage of THC-containing oral fluid in plastic containers 
led to a poor recovery of THC during quantitative analysis, supporting the view that THC 
binds with plastic surfaces. We have demonstrated that the loss of THC to plastic surfaces 
when in the neat oral fluid matrix is relative to the surface area to volume ratio with larger 
ratios resulting in a greater loss. Choi et al. [7] made a similar observation when they found 
that a higher THC loss over 6 days occurred in polypropylene containers of a larger internal 
diameter. This can be explained by the larger surface area to volume ratio of the containers 
with larger internal diameter. We anticipated that lower concentrations of THC would lead to 
a higher loss as there might be less competition for adsorbing space on the plastic surface; 
however this was not observed under our experimental conditions. This may be due to the 
presence of proteins or other materials in oral fluid which binds with THC and help keep it 
from adsorbing to the container surface. This was shown to be likely since the supernatants of 
centrifuged samples had such a low recovery of THC compared to the protein-rich 
reconstitute (Figure 4). Additionally, a very low recovery was found from plain phosphate 
buffer when compared to oral fluid spiked at the same THC concentration in the same 
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volumes, which further supports the possible role of proteins in binding THC in oral fluid.  
Protein binding of THC also explains the low absolute recovery of both THC and d3-THC 
observed from oral fluid during the liquid–liquid extraction process conducted in glass test 
tubes compared to the much higher recovery when extracting from plain phosphate buffer. It 
is noteworthy that at this stage we do not know what specific component or components in 
the protein-rich fraction of oral fluid are responsible for binding THC.  During the course of 
our investigation, it was demonstrated that the THC had not degraded in the short term since 
the addition of non-ionic surfactant Triton® X-100 increased recovery of the spiked THC to 
almost 100%. Other researchers have previously published papers describing loss of THC 
over time [8, 11], but none have given data on immediate losses.  
We have previously reported that THC has excellent stability in the Cozart® buffer with an 
average recovery of 89% when stored in a refrigerator (4 °C) for 13–18 months [12]. The 
current study found that even at room temperature (20 °C, in the dark), there is minimal loss 
over a 4-week period. Ventura et al. [13] reported that adding sodium azide (0.1%) to oral 
fluid helped to prevent degradation of several illicit drugs during up to 7 days of storage at 
25 °C and 37 °C and up to 2 months at 4 °C and –20 °C. Sodium azide is also utilised in 
many commercial oral fluid collecting buffers including the Cozart® DDS buffer which 
contains 0.1% sodium azide. In our study, sodium azide did not seem to give any benefit over 
phosphate buffer as an additive to reduce loss as both sets of samples showed a loss of almost 
25% from refrigerated samples and over 50% from the room temperature samples after a 4-
week period of time. Our results show that azide has no protective effect on THC in oral fluid, 
at least not over the 4-week period studied, although its long term (>4 weeks) effect remains 
to be further studied.  Conversely, the samples stored in Cozart® DDS buffer were only 
observed to lose 10% of added THC when refrigerated and 15% at room temperature after 
four weeks of storage. This study avoided the adsorption issue by adding Triton® X-100 
during sample analysis since we have shown this significantly increases recovery of THC 
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from plastic surfaces. Therefore we can assume that the losses seen in our study are due to the 
degradation of THC and not adsorption. We can also assume that since the addition of 
sodium azide in large excess would have prevented microbial growth, the degradation losses 
of THC observed under our experimental conditions are not due to microbial action but to 
other factors such as oxidative degradation. Moore et al. [14] previously reported that THC 
loss during storage may be exacerbated by chemical reactions induced by oxygen or other 
environmental factors such as fluorescent lighting. Exposure to light and oxygen was 
minimised during the current study by storage in the dark and the relatively small space 
available in the storage tubes used. This may explain the difference between these results and 
our previous finding that more than 50% of the spiked THC was lost in just 1 day after 
storage at room temperature when larger tubes were used and left on the bench [12]. These 
results suggest that addition of anti-oxidants rather than azide into oral fluid may be more 
beneficial in THC preservation. Given the importance of detecting THC in oral fluid to 
society, further research into understanding other factors that govern the behaviour of THC in 
the biological matrix is warranted. 
 
5. Conclusions 
It was demonstrated that THC had the tendency to bind to polypropylene surfaces, leading to 
poor extraction recovery in neat oral fluid.  The recovery of THC is dependent on the oral 
fluid volume to inner surface area ratio; smaller oral fluid volume in larger containers 
suffered from a higher loss of THC. Use of Triton® X-100 can significantly increase the THC 
recovery from polypropylene containers. 
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Tables and Figures 
Table 1. Intra- and inter-day precision and accuracy results for the LOQ and QC samples  















5 3.14 9.73 1.81 8.32 
15 8.57 6.48 8.18 1.99 
75 2.52 1.38 6.37 5.37 
 
 

























Figure 1. Recovery of THC from polypropylene tubes at various concentrations in 1.5 mL 
oral fluid. Data values represent the mean; error bars represent the standard deviation (n = 3). 
 
 
Page 14 of 17 
 
 
Figure 2. Recovery of THC from oral fluid volumes of 0.5, 1.0 and 1.5 mL not treated 
(normal) and treated with 0.25% Triton® X-100, all spiked at 100 ng/mL THC in 
polypropylene tubes. Data values represent the mean; error bars represent the standard 
deviation (n = 5). 
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Figure 3. GC–MS chromatograms showing increased signal intensity from 1 mL oral fluid 
samples spiked with 100 ng/mL THC and internal standard after transfer and extraction: (a) 
m/z 371 (THC) from a Triton® X-100-treated sample; (b) m/z 371 from an untreated sample; 
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Figure 4. Recovery of THC from the supernatant and reconstitute of protein pellets after 
centrifugation of oral fluid samples. THC was spiked at 100 ng/mL in polypropylene tubes. 
Samples without treatment of Triton® X-100 (normal) are represented on the left, on the right 
are the samples treated with Triton® X-100 after supernatant was removed. Data values 




























Figure 5. Comparison of THC recovered from phosphate buffer and oral fluid spiked into 0.5 
and 1.5 mL at 100 ng/mL concentration in polypropylene tubes. Data values represent the 
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Figure 6. Percentage of THC remaining in oral fluid during storage from 3 to 28 days in the 
presence of 0.1 M phosphate buffer, 0.75% sodium azide solution and Cozart® DDS buffer 
solution. Results were means from 4 repeated experiments (n = 4) with standard deviations 
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